Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
Browsing: Emerging Diseases
In this interview, we speak to Ana Litvintseva, a Medical Mycologist and Team Lead at the Centers for Disease Control and Prevention (CDC; GA, USA) about Candida auris, its emergence and the challenges it presents.
Researchers have revealed that arteriviruses may produce more mRNAs and proteins than previously understood – a finding that could provide insight on how the virus may potentially evolve to infect humans.
More than a century after its description and the discovery of the bacterial etiological agent, and despite its major burden globally, leptospirosis remains largely under-recognized.
Author, Mark Woolhouse, discusses recent efforts to identify pathogens with pandemic potential and his own work on emerging viruses.
Editor, Martha Powell, takes a closer look at MERS, Nipah and Lassa; considering their impact on populations thus far and why medical countermeasures against them are so urgently required.
Researchers have suggested Zika may have adverse effects on the cardiovascular system based on new data from a small case report; an association which has previously been unreported.
Editor, Martha Powell, welcomes you to Infectious Diseases Hub and highlights some of the exciting content featured for launch.